ESGO/ISUOG/IOTA/ESGE Consensus Statement on preoperative diagnosis of ovarian tumours
Authors:
- D TimmermanDTD Timmerman
- F PlanchampFPF Planchamp
- T BourneTBT Bourne
- C LandolfoCLC Landolfo
- A du BoisABA du Bois
- L ChivaLCL Chiva
- D CibulaDCD Cibula
- N ConcinNCN Concin
- D FischerovaDFD Fischerova
- W FroymanWFW Froyman
- G GallardoGGG Gallardo
- B LemleyBLB Lemley
Open Access
- 30 June 2021
- journal article
- research article
- Published by Galenos Yayinevi in Human Reproduction Open
- Vol. 13 (2) , 107-130
Abstract
The European Society of Gynaecological Oncology (ESGO), the International Society of Ultrasound in Obstetrics and Gynecology (ISUOG), the International Ovarian Tumour Analysis (IOTA) group and the European Society for Gynaecological Endoscopy (ESGE) jointly developed clinically relevant and evidence-based statements on the preoperative diagnosis of ovarian tumours, including imaging techniques, biomarkers and prediction models. ESGO/ISUOG/IOTA/ESGE nominated a multidisciplinary international group, including expert practising clinicians and researchers who have demonstrated leadership and expertise in the preoperative diagnosis of ovarian tumours and management of patients with ovarian cancer (19 experts across Europe). A patient representative was also included in the group. To ensure that the statements were evidence-based, the current literature was reviewed and critically appraised. Preliminary statements were drafted based on the review of the relevant literature. During a conference call, the whole group discussed each preliminary statement and a first round of voting was carried out. Statements were removed when a consensus among group members was not obtained. The voters had the opportunity to provide comments/suggestions with their votes. The statements were then revised accordingly. Another round of voting was carried out according to the same rules to allow the whole group to evaluate the revised version of the statements. The group achieved consensus on 18 statements. This Consensus Statement presents these ESGO/ISUOG/IOTA/ESGE statements on the preoperative diagnosis of ovarian tumours and the assessment of carcinomatosis, together with a summary of the evidence supporting each statement.Keywords
This publication has 187 references indexed in Scilit:
- Are serum HE4 or ROMA scores useful to experienced examiners for improving characterization of adnexal masses after transvaginal ultrasonography?Ultrasound in Obstetrics & Gynecology, 2013
- Comparison of HE4, CA125 and ROMA algorithm in women with a pelvic mass: Correlation with pathological outcomeGynecologic Oncology, 2013
- Imaging in gynecological disease (8): ultrasound characteristics of recurrent borderline ovarian tumorsUltrasound in Obstetrics & Gynecology, 2012
- Subjective assessment by ultrasound is superior to the risk of malignancy index (RMI) or the risk of ovarian malignancy algorithm (ROMA) in discriminating benign from malignant adnexal massesEuropean Journal of Cancer, 2012
- Does risk for ovarian malignancy algorithm excel human epididymis protein 4 and ca125 in predicting epithelial ovarian cancer: A meta-analysisBMC Cancer, 2012
- Ultrasound criteria and CA 125 as predictive variables of ovarian cancer in women with adnexal tumorsUltrasound in Obstetrics & Gynecology, 2012
- Comparison of four malignancy risk indices in the detection of malignant ovarian massesJournal of Gynecologic Oncology, 2011
- Correlates of the preoperative level of CA125 at presentation of ovarian cancerGynecologic Oncology, 2010
- Serum CA19.9 levels are commonly elevated in primary ovarian mucinous tumours but cannot be used to predict the histological subtypeJournal of Clinical Pathology, 2010
- Diagnostic accuracy of 18F-FDG PET/CT in characterizing ovarian lesions and staging ovarian cancer: Correlation with transvaginal ultrasonography, computed tomography, and histologyNuclear Medicine Communications, 2007